Repetitive Transcranial Magnetic Stimulation (rTMS) of the Insula for Treatment of Alcohol Addiction
1 other identifier
interventional
84
1 country
1
Brief Summary
The purpose of this study is to investigate the effects of repetitive transcranial magnetic stimulation (rTMS) targeting the insula on alcohol use and neural responses in alcohol-dependent patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2015
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 21, 2015
CompletedFirst Posted
Study publicly available on registry
December 31, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedDecember 31, 2015
December 1, 2015
2.1 years
December 21, 2015
December 28, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Heavy Drinking
Reduction in heavy alcohol use during the outpatient follow-up phase (%heavy drinking days) measured by standard Time-Line Follow-Back methodology
12 weeks follow-up from treatment completion
Insula activity
Insula activity (%signal change, as measured by fMRI BOLD), during a task known to be associated with insula responses, risky decision making
Within 5 days of treatment completion
Secondary Outcomes (5)
BOLD responses in a battery of standard fMRI tasks that probe processing of alcohol-associated cues, reward function, and emotional responses.
Within 5 days after the last TMS session
Alterations in resting-state connectivity of the insula with other nodes in the putative Salience Network (SN), executive control network (ECN) and the default-mode network (DMN) by rTMS.
Within 5 days after the last TMS session
Objective biomarkers of alcohol use
12 weeks follow-up from treatment completion
Alcohol craving and psychiatric symptoms
12 weeks follow-up from treatment completion
Smoking
12 weeks follow-up from treatment completion
Study Arms (2)
rTMS 10 Hz
EXPERIMENTALDeep Repetitive Transcranial Magnetic Stimulation (rTMS, 10 Hz) of the insula ,15 stimulation sessions (1 daily, 5 days / week).
rTMS Sham
SHAM COMPARATORSham Repetitive Transcranial Magnetic Stimulation (rTMS, Sham),15 stimulation sessions (1 daily, 5 days / week).
Interventions
Participants will receive a total of 15 sessions of rTMS targeting the insula bilaterally, Stimulation will be delivered at an intensity of 120% of the motor threshold (MT), with a frequency of 10 Hz, delivered as 50 trains of 30 pulses delivered in each train of 3 seconds duration, with a 20 seconds inter-train interval, for a total of 1500 pulses delivered over app. 20 min. On the very first two sessions stimulations will be given at lower strength for adaptation, starting at 100% for the first and 110% for the second session
Eligibility Criteria
You may qualify if:
- Age 18 - 65
- Current Diagnostic and Statistical Manual (DSM-IV-TR) diagnosis of alcohol dependence
- Alcohol use in the past month
- Right handed (self-report)
- If female, negative urine pregnancy test
- If female, must either agree to practice an effective birth control method; have a partner with a vasectomy; agree to abstinence from intercourse; be surgically sterile or postmenopausal for at least one year
You may not qualify if:
- Currently pregnant or breastfeeding
- More than mild cognitive impairment, as determined by a score on the Mini Mental State Examination (MMSE) \<24.
- Current DSM-IV diagnosis of schizophrenia, bipolar disorder, or other psychotic disorder
- Use in the past 4 weeks of any medication or illicit drug listed as being associated with "a strong potential hazard for application of rTMS due to their significant seizure threshold lowering potential" by the international consensus guidelines for delivery of TMS \[104\], as self-reported, or detected using urine toxicology screening
- Any history of clinically significant neurological disorders, including organic brain disease, epilepsy, stroke, brain lesions, multiple sclerosis, previous neurosurgery or personal history of head trauma that resulted in loss of consciousness for \> 5 minutes and retrograde amnesia for \> 30 minutes (self-reported history).
- Any history of seizures other than febrile childhood seizures (self-reported history)
- Signs of increased intracranial pressure as determined by the structural MRI-scan
- Clinically significant hearing impairment or tinnitus
- Presence of ferromagnetic objects in the body that are contraindicated for MRI of the head (pacemakers or other implanted electrical devices, brain stimulators, some types of dental implants, aneurysm clips, metallic prostheses, permanent eyeliner, implanted delivery pump, or shrapnel fragments) or fear of enclosed spaces. Eligibility will be determined by the "MRI Safety Screening Questionnaire" (see Appendix 1) and verified, if necessary, by a radiology consultant.
- Cannot recline comfortably flat on his/her back for up to 2 hours in the MRI scanner.
- Any psychiatric, medical or social condition whether or not listed above, due to which, in the judgment of the investigators and after any consults if indicated, participation in the study is not in the best interest of the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Linkoping University
Linköping, 581 85, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Markus A Heilig, MD PhD
Linkoeping University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 21, 2015
First Posted
December 31, 2015
Study Start
November 1, 2015
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
December 31, 2015
Record last verified: 2015-12
Data Sharing
- IPD Sharing
- Will share